Parasitexx

Manufacturer
Dannso Corp./d.b.a. Essential Products | All Pharma LLC
Effective date
2022-01-02
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 23:47:12

Label at a glance#

ProductParasitexx
Active ingredientPYRANTEL PAMOATE
Label structure12 sections

Indications and uses

For the treatment of pinworms.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient (in each 1 ml) Purpose

Active Ingredient (in each 1 ml) Purpose
PYRANTEL PAMOATE Pinworm Treatment

Inactive Ingredient

INACTIVE INGREDIENT SECTION

acesulfame potassium, cherry flavor, citric acid, glycerin, polysorbate 80, potassium sorbate, propylene glycol, sodium benzoate, sodium carboxymethylcellulose, sodium citrate, sorbitol, water, xanthan gum.

Dosage

DOSAGE & ADMINISTRATION SECTION

Directions Read package insert careful before taking this medication. Take only according to directions and do not exceed the recommended dosage unless directed by a doctor. Medication should only be taken one time as a single dose; do not repeat treatment unless directed by a doctor. When one individual in a household has pinworms, the entire household should be treated unless otherwise advised. See warnings. If any worms other than pinworms are present before or after treatment, or pinworms are still present after treatment, consult a doctor.

WEIGHTS SINGLE DOSE
Less than 26 pounds or under 2 years of age Do not use unless directed by a doctor
25 to 37 pounds ½ teaspoonful (2.5 ml)
38 to 62 pounds 1 teaspoonful (5 ml)
63 to 87 pounds 1 ½ teaspoonfuls (7.5 ml)
88 to 112 pounds 2 teaspoonfuls (10 ml)
113 to 137 pounds 2 ½ teaspoonfuls (12.5 ml)
138 to 162 pounds 3 teaspoonfuls (15 ml)
163 to 187 pounds 3 ½ teaspoonfuls (17.5 ml)
188 pounds and over 4 teaspoonfuls (20 ml)

Shake well before use. This product can be taken any time of the day, with or without meals. It may be taken alone or with milk or juice. Use of a laxative is not necessary prior to, during, or after medication.

Uses

OTC - PURPOSE SECTION

For the treatment of pinworms.

Warnings

WARNINGS SECTION

Do not exceed recommended dosage. When using this product abdominal cramps, nausea, diarrhea. Headache, or dizziness sometimes occurs after taking this drug. If this condition persists consult doctor.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have liver disease.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

INDICATIONS & USAGE SECTION

Uses for the treatment of pinworns

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental overdose, seek medical attention or contact a Poison Control Center immediately.

Other information

OTHER SAFETY INFORMATION

Protect from excessive heat and freezing. Store at room temperature.

Tamper-Evident Feature: do not use if printed seal around bottle neck is torn, broken or missing.

OTC - QUESTIONS SECTION

Questions? 305-261-8762
Monday – Friday 9am to 5pm EST.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image of cartonimage of carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1927875Parasitexx 144 MG in 1 mL Oral SuspensionPSN3
199106pyrantel pamoate 144 MG in 1 mL Oral SuspensionPSN3
1927875pyrantel pamoate 144 MG/ML Oral Suspension [Parasitexx]SBD3
199106pyrantel pamoate 144 MG/ML Oral SuspensionSCD3
1927875Parasitexx 144 MG/ML (pyrantel base 50 MG/ML) Oral SuspensionSY3
1927875Parasitexx 144 MG/ML Oral SuspensionSY3
199106pyrantel pamoate 144 MG per 1 ML Oral SuspensionSY3
199106pyrantel pamoate 144 MG/ML (pyrantel base 50 MG/ML) Oral SuspensionSY3

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70242-134-052023-07-28C16284748780-19d75b9d1-0f1b-f424-e053-dadaa90a57cePARASITEXX
70242-134-052020-08-05C16284748780-19d75b9d1-0f1b-f424-e053-dadaa90a57cePARASITEXX
70242-134-052020-01-31C16284748780-19d75b9d1-0f1b-f424-e053-dadaa90a57cePARASITEXX

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70242-134-05Parasitexx30 mL in 1 BOTTLESUSPENSION303
70242-134-05Parasitexx1 in 1 CARTONSUSPENSION13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70242-134PARASITEXX (PYRANTEL PAMOATE) SUSPENSION [DANNSO CORP./D.B.A. ESSENTIAL PRODUCTS]3Legacy NDC, 2 package rows20220120_89e718f3-2c6e-408e-a627-9d0bd60feff1.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70242-13470242-134-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ad61b208-3ed8-44d4-a8b1-45c99fa8171b89e718f3-2c6e-408e-a627-9d0bd60feff12022-01-02WarningsExact identifier
spl id: ad61b208-3ed8-44d4-a8b1-45c99fa8171b
spl set id: 89e718f3-2c6e-408e-a627-9d0bd60feff1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.